Phosphoramidites

2'-Fluoro-2'-deoxy Guanosine (N-iPrPAC) 3'-O-BMEG phosphoramidite

Description: 2'-Fluoro-2'-deoxy Guanosine (N-iPrPAC) 3'-O-BMEG phosphoramidite is a phosphoramidite reagent used in the synthesis of modified nucleic acids. This compound is specifically designed to incorporate a modified guanosine nucleoside into oligonucleotide sequences, enhancing their stability and functionality. It serves as an intermediate in automated DNA and RNA synthesis platforms, facilitating precise and reliable incorporation of modified nucleotides into sequence-defined oligonucleotides. This capability is crucial in various biomedical research applications, including gene editing, RNA interference (RNAi), and molecular diagnostics, where modified nucleic acids provide improved stability, specificity, and functionality.

CAT: BRP-01597

MF: C56H70FN6O11PS

MF: 1085.24

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: YCAKSFKUVSLOLZ-IUVNWIHYSA-N

IUPAC Name: S-(2-(2-(((((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluoro-5-(2-(2-(4-isopropylphenoxy)acetamido)-6-oxo-1,6-dihydro-9H-purin-9-yl)tetrahydrofuran-3-yl)oxy)(diisopropylamino)phosphaneyl)oxy)ethoxy)ethyl) 2-methylpropanethioate

InChI: InChI=1S/C56H70FN6O11PS/c1-35(2)39-16-22-45(23-17-39)70-33-47(64)59-55-60-51-49(52(65)61-55)58-34-62(51)53-48(57)50(74-75(63(37(5)6)38(7)8)72-29-28-69-30-31-76-54(66)36(3)4)46(73-53)32-71-56(40-14-12-11-13-15-40,41-18-24-43(67-9)25-19-41)42-20-26-44(68-10)27-21-42/h11-27,34-38,46,48,50,53H,28-33H2,1-10H3,(H2,59,60,61,64,65)/t46-,48-,50-,53-,75?/m1/s1

Synonyms: 5'-O-DMTr-2'-F-dG(iPr-Pac)-3'-O-BMEG phosphoramidite

2'-Fluoro-2'-deoxy Uridine 3'-O-BMEG phosphoramidite

Description: 2'-Fluoro-2'-deoxy Uridine 3'-O-BMEG phosphoramidite is a phosphoramidite reagent used in the synthesis of modified nucleic acids, specifically incorporating a modified uridine nucleoside into oligonucleotide sequences. It facilitates the synthesis of nucleic acids with enhanced stability and functionality. It serves as an intermediate in automated DNA and RNA synthesis, enabling precise incorporation of modified uridine nucleotides into sequence-defined oligonucleotides. This capability supports various biomedical research applications, including gene therapy, RNA interference (RNAi), and molecular diagnostics, where modified nucleic acids offer improved performance in terms of stability, specificity, and functionality.

CAT: BRP-01598

CAS: 1219597-57-5

MF: C44H57FN3O10PS

MF: 869.98

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: MQTFINZTMLJCIH-KVTBCOQSSA-N

CanonicalSMILES: CC(C)C(=O)SCCOCCOP(N(C(C)C)C(C)C)OC1C(OC(C1F)N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC

IUPAC Name: S-[2-[2-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(2,4-dioxopyrimidin-1-yl)-4-fluorooxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxyethoxy]ethyl] 2-methylpropanethioate

InChI: InChI=1S/C44H57FN3O10PS/c1-29(2)42(50)60-27-26-54-24-25-56-59(48(30(3)4)31(5)6)58-40-37(57-41(39(40)45)47-23-22-38(49)46-43(47)51)28-55-44(32-12-10-9-11-13-32,33-14-18-35(52-7)19-15-33)34-16-20-36(53-8)21-17-34/h9-23,29-31,37,39-41H,24-28H2,1-8H3,(H,46,49,51)/t37-,39-,40-,41-,59?/m1/s1

Synonyms: 5'-O-DMTr-2'-F-dU-3'-O-BMEG phosphoramidite; S-(2-(2-(((((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-3-yl)oxy)(diisopropylamino)phosphaneyl)oxy)ethoxy)ethyl) 2-methylpropanethioate; Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-, 3'-[2-[2-[(2-methyl-1-oxopropyl)thio]ethoxy]ethyl N,N-bis(1-methylethyl)phosphoramidite]

2'-Fluoro-2'-deoxy Adenosine (N-PAC) 3'-O-BMEG phosphoramidite

Description: 2'-Fluoro-2'-deoxy Adenosine (N-PAC) 3'-O-BMEG phosphoramidite is a phosphoramidite reagent used in the synthesis of modified nucleic acids, specifically designed to incorporate a modified adenosine nucleoside into oligonucleotide sequences. It serves as an intermediate in automated DNA and RNA synthesis platforms. This reagent is essential in biomedical research applications such as gene editing, RNA interference (RNAi), and molecular diagnostics, where modified nucleic acids are utilized for improved stability, specificity, and functional properties.

CAT: BRP-01599

MF: C53H64FN6O10PS

MF: 1027.15

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: ULXOJEKGELECAK-BIRYJSLWSA-N

IUPAC Name: S-(2-(2-(((((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluoro-5-(6-(2-phenoxyacetamido)-9H-purin-9-yl)tetrahydrofuran-3-yl)oxy)(diisopropylamino)phosphaneyl)oxy)ethoxy)ethyl) 2-methylpropanethioate

InChI: InChI=1S/C53H64FN6O10PS/c1-35(2)52(62)72-30-29-65-27-28-68-71(60(36(3)4)37(5)6)70-48-44(31-67-53(38-15-11-9-12-16-38,39-19-23-41(63-7)24-20-39)40-21-25-42(64-8)26-22-40)69-51(46(48)54)59-34-57-47-49(55-33-56-50(47)59)58-45(61)32-66-43-17-13-10-14-18-43/h9-26,33-37,44,46,48,51H,27-32H2,1-8H3,(H,55,56,58,61)/t44-,46-,48-,51-,71?/m1/s1

Synonyms: 5'-O-DMTr-2'-F-dA(Pac)-3'-O-BMEG phosphoramidite

5-O-DMTr-1-O-Ac-2-F-2-deoxyribofuranose-3-CE-Phosphoramidite

Description: 5-O-DMTr-1-O-Ac-2-F-2-deoxyribofuranose-3-CE-Phosphoramidite is a phosphoramidite reagent used in oligonucleotide synthesis. It features a deoxyribose sugar with specific modifications: the 5'-hydroxyl group is protected by a dimethoxytrityl (DMTr) group, the 1'-hydroxyl group is acetylated (Ac), and a fluorine atom is substituted at the 2' position. These modifications enhance the stability and functionality of the nucleic acids. The 3'-cyanoethyl (CE) phosphoramidite group is crucial for the automated synthesis process, enabling efficient and precise addition of this modified sugar to the growing oligonucleotide chain. This reagent is valuable in the synthesis of stable and functional nucleic acid sequences for various research and therapeutic applications.

CAT: BRP-01606

MF: C37H46FN2O8P

MF: 696.75

Purity: ≥95% by UPLC

Appearance: White or off-white to light yellow powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: YXVIYDHRSOENQP-NDCODMSPSA-N

IUPAC Name: (3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(((2-cyanoethoxy)(diisopropylamino)phosphaneyl)oxy)-3-fluorotetrahydrofuran-2-yl acetate

InChI: InChI=1S/C37H46FN2O8P/c1-25(2)40(26(3)4)49(45-23-11-22-39)48-35-33(47-36(34(35)38)46-27(5)41)24-44-37(28-12-9-8-10-13-28,29-14-18-31(42-6)19-15-29)30-16-20-32(43-7)21-17-30/h8-10,12-21,25-26,33-36H,11,23-24H2,1-7H3/t33-,34-,35-,36?,49?/m1/s1

Synonyms: 5-O-(4,4'-Dimethoxytrityl)-1-O-acetyl-2-fluoro-2-deoxyribofuranose-3-cyanoethyl Phosphoramidite

5-DMTr-2-F-1,2-dideoxyribose-3-CE-Phosphoramidite

Description: 5-DMTr-2-F-1,2-dideoxyribose-3-CE-Phosphoramidite is a key reagent in the synthesis of modified oligonucleotides, featuring a dideoxyribose sugar with a 5'-dimethoxytrityl (DMTr) protective group and a fluorine atom at the 2' position. The dideoxyribose lacks hydroxyl groups at both the 1' and 2' positions, except for the 3'-hydroxyl, which is modified with a cyanoethyl (CE) phosphoramidite group. This design increases the stability of the oligonucleotide and prevents chain extension at the 2' position. This reagent is particularly useful for creating stable, modified oligonucleotides for use in various molecular biology and therapeutic applications.

CAT: BRP-01607

MF: C35H44FN2O6P

MF: 638.72

Purity: ≥98% by HPLC

Appearance: White or off-white to faint yellow solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: CYNXGQPRPXHCQI-PRVDSXFMSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(COC1COC(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)C4=CC=C(C=C4)OC)F

IUPAC Name: 3-[[(2R,3R,4S)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-fluorooxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C35H44FN2O6P/c1-25(2)38(26(3)4)45(43-22-10-21-37)44-34-32(36)23-41-33(34)24-42-35(27-11-8-7-9-12-27,28-13-17-30(39-5)18-14-28)29-15-19-31(40-6)20-16-29/h7-9,11-20,25-26,32-34H,10,22-24H2,1-6H3/t32-,33+,34-,45?/m0/s1

Synonyms: 5-O-(4,4'-Dimethoxytrityl)-2-fluoro-1-deoxyribose-3-cyanoethyl Phosphoramidite; (2R,3R,4S)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

3'-F-3'-dA(Bz)-2'-phosphoramidite

Description: 3'-F-3'-dA(Bz)-2'-phosphoramidite, an indispensable compound widely employed in the biomedical sector for the synthesis of oligonucleotides and nucleic acid analogs, holds paramount importance. Its modified structure renders it adept at enhancing stability, selectivity, and binding properties.

CAT: BRP-01609

CAS: 2127174-09-6

MF: C47H51FN7O7P

MF: 875.92

Purity: ≥95%

Appearance: Off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: WTXSTLCSPVTJTM-MSIRFHFKSA-N

Solubility: Soluble in Acetonitrile, DMF

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(C(OC1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)F

IUPAC Name: (2R,3S,4R,5R)-2-(6-benzamido-9H-purin-9-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C47H51FN7O7P/c1-31(2)55(32(3)4)63(60-27-13-26-49)62-42-40(48)39(61-46(42)54-30-52-41-43(50-29-51-44(41)54)53-45(56)33-14-9-7-10-15-33)28-59-47(34-16-11-8-12-17-34,35-18-22-37(57-5)23-19-35)36-20-24-38(58-6)25-21-36/h7-12,14-25,29-32,39-40,42,46H,13,27-28H2,1-6H3,(H,50,51,53,56)/t39-,40-,42-,46-,63?/m1/s1

Synonyms: N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-deoxy-3'-fluoroadenosine-2'-CED-phosphoramidite; N-[9-[(2R,3S,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-4-fluorooxolan-2-yl]purin-6-yl]benzamide; N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-2'-O-[(2-cyanoethoxy)(diisopropylamino)phosphino]-3'-deoxy-3'-fluoroadenosine; 5'-DMT-3'-fluoro-DA(BZ) amidite; 3'-F A(Bz) 2'-amidite

5'-O-DMTr-2'-OMeU-methylphosphonamidite

Description: 5'-O-DMTr-2'-OMeU-methylphosphonamidite is an indispensable recompound widely employed in the field of compound, exhibiting immense significance in the research and development of altered oligonucleotides meticulously crafted for gene therapy and medicinal chemistry. Moreover, it assumes a pivotal role in the research and development of antisense oligonucleotides explicitly engineered to combat genetic disorders, infectious ailments and select malignancies.

CAT: BRP-01610

CAS: 191786-64-8

MF: C38H48N3O8P

MF: 705.78

Purity: ≥95%

Appearance: Off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: OMQYBRGCCIXKCN-IFQFNZHASA-N

Solubility: Soluble in Acetonitrile, DMF

CanonicalSMILES: CC(C)N(C(C)C)P(C)OC1C(OC(C1OC)N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC

IUPAC Name: 1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[[di(propan-2-yl)amino]-methylphosphanyl]oxy-3-methoxyoxolan-2-yl]pyrimidine-2,4-dione

InChI: InChI=1S/C38H48N3O8P/c1-25(2)41(26(3)4)50(8)49-34-32(48-36(35(34)46-7)40-23-22-33(42)39-37(40)43)24-47-38(27-12-10-9-11-13-27,28-14-18-30(44-5)19-15-28)29-16-20-31(45-6)21-17-29/h9-23,25-26,32,34-36H,24H2,1-8H3,(H,39,42,43)/t32-,34-,35-,36-,50?/m1/s1

Synonyms: Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'-[P-methyl-N,N-bis(1-methylethyl)phosphonamidite]; 5'-O-DMTr-2'-O-methyluridine-3'-O-(P-methyl-N,N-diisopropylamino)phosphonamidite; 2'-OMe U Me-amidite; 1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(((diisopropylamino)(methyl)phosphaneyl)oxy)-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 5'-O-DMTr-2'-OMe-U-3'-O-[P-methyl-(N,N-diisopropyl)]-Phosphoramidite; 5'-O-(4,4'-dimethoxytrityl)-2'-OMe-uridine-3'-O-[P-methyl-(N,N-diisopropyl)]-Phosphoramidite; 2'-O-Methyl Uridine p-methyl phosphonamidite

5'-Cholesterol-CE Phosphoramidite (BRP-01617)

Description: 5'-Cholesterol-CE Phosphoramidite is a powerful substance made entirely from plant-derived cholesterol that has the ability to fight hypercholesterolemia and various lipid disorders. Using innovative technology, it inhibits cholesterol synthesis in the liver, thereby reducing overall blood cholesterol levels. Due to its remarkable effectiveness, it is highly valued in the biopharmaceutical industry and widely used in the treatment of cardiovascular diseases.

CAT: BRP-01617

CAS: 143723-64-2

MF: C43H76N3O4P

MF: 730.07

Purity: >95%

Appearance: Light-yellow oily matter

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

Boiling Point: 722.5±60.0 °C at 760 mmHg

InChIKey: LLDRAIRYAJXEEP-CRQKJHHESA-N

Solubility: Soluble in Acetonitrile, DMF

CanonicalSMILES: CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)NCCCCCCOP(N(C(C)C)C(C)C)OCCC#N)C)C

IUPAC Name: [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] N-[6-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxyhexyl]carbamate

InChI: InChI=1S/C43H76N3O4P/c1-31(2)16-14-17-34(7)38-20-21-39-37-19-18-35-30-36(22-24-42(35,8)40(37)23-25-43(38,39)9)50-41(47)45-27-12-10-11-13-28-48-51(49-29-15-26-44)46(32(3)4)33(5)6/h18,31-34,36-40H,10-17,19-25,27-30H2,1-9H3,(H,45,47)/t34-,36+,37+,38-,39+,40+,42+,43-,51?/m1/s1

Synonyms: Cholesteryl-3-carboxamidohexyl-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; Cholest-5-en-3-ol (3β)-, 3-[[6-[[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]oxy]hexyl]carbamate]; Cholest-5-en-3-ol (3β)-, [6-[[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]oxy]hexyl]carbamate; Cholest-5-en-3-ol, 3-(6-(((2-cyanoethoxy)(diisopropylamino)phosphino)oxy)hexyl)carbemate; Cholesterol C6 amine amidite; Cholesteryl-3-carboxamidohexyl-[2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite

U-(S)-GNA phosphoramidite

Description: U-(S)-GNA phosphoramidite, a chemical reagent frequently employed in the synthesis of modified oligonucleotides, has demonstrated its utility in the development of RNA therapeutics for diseases spanning cancer to viral infections. The structural distinctiveness of this reagent affords the resulting oligonucleotides improved stability and efficacy.

CAT: BRP-01619

CAS: 494784-15-5

MF: C37H45N4O7P

MF: 688.75

Purity: ≥98%

Appearance: Light yellow solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: KZZGGKJIAMPACS-AQXIKWHWSA-N

Solubility: Soluble in Acetonitrile, DMF

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC(CN1C=CC(=O)NC1=O)COC(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)C4=CC=C(C=C4)OC

IUPAC Name: 3-[[(2S)-1-[bis(4-methoxyphenyl)-phenylmethoxy]-3-(2,4-dioxopyrimidin-1-yl)propan-2-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C37H45N4O7P/c1-27(2)41(28(3)4)49(47-24-10-22-38)48-34(25-40-23-21-35(42)39-36(40)43)26-46-37(29-11-8-7-9-12-29,30-13-17-32(44-5)18-14-30)31-15-19-33(45-6)20-16-31/h7-9,11-21,23,27-28,34H,10,24-26H2,1-6H3,(H,39,42,43)/t34-,49?/m0/s1

Synonyms: GNA U amidite; Phosphoramidous acid, bis(1-methylethyl)-, (1S)-2-[bis(4-methoxyphenyl)phenylmethoxy]-1-[(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)methyl]ethyl 2-cyanoethyl ester; (S)-GNA-U-phosphoramidite; DMT-U-(S)-GNA Phosphoramidite; (S)-1-(bis(4-methoxyphenyl)(phenyl)methoxy)-3-(2,4-dioxo-3, 4-dihydropyrimidin-1(2H)-yl)propan-2-yl(2-cyanoethyl)diisopropylphosphoramidite

N6-Benzoyl-5'-O-DMT-3'-O-methyladenosine 3'-CE-phosphoramidite

Description: N6-Benzoyl-5'-O-DMT-3'-O-methyladenosine 3'-CE-phosphoramidite is a highly specialized chemical compound utilized in the synthesis of novel RNA molecules. Its unparalleled structural complexity enables precise targeting of malignant cells, paving the way for enhanced efficacy in RNA-based therapeutics that aim to alleviate various ailments, such as cancer and viral infections. Such unprecedented capability in modulating gene expression makes N6-Benzoyl-5'-O-DMT-3'-O-methyladenosine 3'-CE-phosphoramidite an invaluable tool in cutting-edge genetic research.

CAT: BRP-01620

CAS: 179479-02-8

MF: C48H54N7O8P

MF: 887.97

Purity: >95%

Appearance: Off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: FVQVZAFXDJSVIC-PSVHYZMASA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(C(OC1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)OC

IUPAC Name: N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-4-methoxyoxolan-2-yl]purin-6-yl]benzamide

InChI: InChI=1S/C48H54N7O8P/c1-32(2)55(33(3)4)64(61-28-14-27-49)63-43-42(59-7)40(62-47(43)54-31-52-41-44(50-30-51-45(41)54)53-46(56)34-15-10-8-11-16-34)29-60-48(35-17-12-9-13-18-35,36-19-23-38(57-5)24-20-36)37-21-25-39(58-6)26-22-37/h8-13,15-26,30-33,40,42-43,47H,14,28-29H2,1-7H3,(H,50,51,53,56)/t40-,42-,43-,47-,64?/m1/s1

Synonyms: N6-BZ-5'-O-DMTr-3'-O-methyladenosine-2'-O-CED-phosphoramidite; 3'-OMe A(Bz) 2'-amidite; N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-methyladenosine-2'-cyanoethyl phosphoramidite; Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-O-methyl-, 2'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]; 3'-O-Me-A(Bz)-2'-phosphoramidite; 3'-OMe-A(Bz) Phosphoramidite; 3'-O-Methyl Adenosine (n-bz) CED phosphoramidite

RSPACER CEP

Description: RSPACER CEP is a biomedical product designed to study Chronic Exertional Compartment Syndrome.

CAT: BRP-01621

CAS: 159299-31-7

MF: C41H59N2O7PSi

MF: 750.99

Purity: >95%

Appearance: Off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

InChIKey: URLPBMMJULLWTE-ZEGDCKMFSA-N

Solubility: Soluble in Acetonitrile, DMF

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(COC1COC(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)C4=CC=C(C=C4)OC)O[Si](C)(C)C(C)(C)C

IUPAC Name: 3-[[(2R,3R,4S)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxyoxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C41H59N2O7PSi/c1-30(2)43(31(3)4)51(48-27-15-26-42)49-39-37(46-28-38(39)50-52(10,11)40(5,6)7)29-47-41(32-16-13-12-14-17-32,33-18-22-35(44-8)23-19-33)34-20-24-36(45-9)25-21-34/h12-14,16-25,30-31,37-39H,15,27-29H2,1-11H3/t37-,38+,39-,51?/m1/s1

Synonyms: 5'-O-Dimethoxytrityl-1'-Deoxyribose-2'-O-TBDMS-3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; rSpacer TBDMS CE Phosphoramidite; 2'-OTBS abasic amidite; D-Ribitol, 1,4-anhydro-5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-O-[(1,1-dimethylethyl)dimethylsilyl]-, 3-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]; D-Ribitol, 1,4-anhydro-5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-O-[(1,1-dimethylethyl)dimethylsilyl]-, 2-cyanoethyl bis(1-methylethyl)phosphoramidite

2-Isobutyrylamino-9-(2'-O-tert-butyldimethylsilyl-5'-O-DMT-b-D-ribofuranosyl)purine 3'-CE phosphoramidite

Description: 2-Isobutyrylamino-9-(2'-O-tert-butyldimethylsilyl-5'-O-DMT-b-D-ribofuranosyl)purine 3'-CE phosphoramidite is an essential component in oligonucleotide synthesis for the biomedical industry. It is used in the modification and synthesis of nucleotide sequences targeting specific genes or diseases. Its unique properties allow for efficient and accurate incorporation into DNA and RNA strands, enabling researchers to study and develop therapeutic interventions for various conditions.

CAT: BRP-01622

CAS: 179558-91-9

MF: C50H68N7O8PSi

MF: 954.20

Purity: >95%

Appearance: Off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: XJRKARXGQAQMRG-KAZSGHHBSA-N

Solubility: Soluble in Acetonitrile, DMF

CanonicalSMILES: CCCC(=O)NC1=NC=C2C(=N1)N(C=N2)C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)OP(N(C(C)C)C(C)C)OCCC#N)O[Si](C)(C)C(C)(C)C

IUPAC Name: N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxyoxolan-2-yl]purin-2-yl]butanamide

InChI: InChI=1S/C50H68N7O8PSi/c1-13-18-43(58)54-48-52-31-41-46(55-48)56(33-53-41)47-45(65-67(11,12)49(6,7)8)44(64-66(62-30-17-29-51)57(34(2)3)35(4)5)42(63-47)32-61-50(36-19-15-14-16-20-36,37-21-25-39(59-9)26-22-37)38-23-27-40(60-10)28-24-38/h14-16,19-28,31,33-35,42,44-45,47H,13,17-18,30,32H2,1-12H3,(H,52,54,55,58)/t42-,44-,45-,47-,66?/m1/s1

Synonyms: 2'-OTBS 2-amino(iBu)purine amidite; N-[9-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-O-[(1,1-dimethylethyl)dimethylsilyl]-β-D-ribofuranosyl]-9H-purin-2-yl]butanamide

2'-OMe N3-Me-U amidite

Description: Uridine 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3-methyl-2'-O-methyl-3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] (9CI) finds utility as a phosphoramidite constituent in the construction of distinct DNA sequences for investigative purposes. Uridine analogues, including the aforementioned derivative, have been explored for therapeutic uses against a spectrum of neurological and psychiatric maladies, hence providing an avenue for potential drug discovery.

CAT: BRP-01623

CAS: 911836-90-3

MF: C41H51N4O9P

MF: 774.84

Purity: >95%

Appearance: Off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: SKKGCWPFTMKRMD-BNPGDSBPSA-N

Solubility: Soluble in Acetonitrile, DMF

CanonicalSMILES: N#CCCOP(OC1C(OC(N2C=CC(=O)N(C2=O)C)C1OC)COC(C=3C=CC=CC3)(C4=CC=C(OC)C=C4)C5=CC=C(OC)C=C5)N(C(C)C)C(C)C

IUPAC Name: (2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxy-5-(3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C41H51N4O9P/c1-28(2)45(29(3)4)55(52-26-12-24-42)54-37-35(53-39(38(37)50-8)44-25-23-36(46)43(5)40(44)47)27-51-41(30-13-10-9-11-14-30,31-15-19-33(48-6)20-16-31)32-17-21-34(49-7)22-18-32/h9-11,13-23,25,28-29,35,37-39H,12,26-27H2,1-8H3/t35-,37-,38-,39-,55?/m1/s1

Synonyms: 5'-O-DMTr-N3-methyl-2'-O-methyluridine 3'-CED phosphoramidite; Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3-methyl-2'-O-methyl-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite]

2'-O-tert-Butyldimethylsilyl-5-O-DMT-nebularine 3'-CE phosphoramidite

Description: 2'-O-tert-Butyldimethylsilyl-5-O-DMT-nebularine 3'-CE phosphoramidite is a cutting-edge substance harboring extraordinary potential, catalyzing the research and development of tailored oligonucleotides, augmenting the efficiency and precision of nucleic acid sequence alterations.

CAT: BRP-01624

CAS: 151132-95-5

MF: C46H61N6O7PSi

MF: 869.07

Purity: >95%

Appearance: Off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: PPQDUERYNRWJQB-DFDZFBLHSA-N

Solubility: Soluble in Acetonitrile, DMF

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1O[Si](C)(C)C(C)(C)C)N2C=NC3=CN=CN=C32)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC

IUPAC Name: 3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxy-5-purin-9-yloxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C46H61N6O7PSi/c1-32(2)52(33(3)4)60(56-27-15-26-47)58-41-40(57-44(42(41)59-61(10,11)45(5,6)7)51-31-50-39-28-48-30-49-43(39)51)29-55-46(34-16-13-12-14-17-34,35-18-22-37(53-8)23-19-35)36-20-24-38(54-9)25-21-36/h12-14,16-25,28,30-33,40-42,44H,15,27,29H2,1-11H3/t40-,41-,42-,44-,60?/m1/s1

Synonyms: 9-(2'-O-tert-Butyldimethylsilyl-5'-O-DMT-b-D-ribofuranosyl)purine 3'-CE phosphoramidite; 2'-OTBS Purine amidite; 9-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-O-[(1,1-dimethylethyl)dimethylsilyl]-β-D-ribofuranosyl]-9H-purine; Nebularine 3''-CE phosphoramidite; Purine Riboside CED phosphoramidite

Cytidine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-N-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]

Description: Cytidine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-N-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] is an exceptional and multifarious pharmaceutical compound. With its distinctive chemical configuration, this exquisite compound exerts effects in research of a range of maladies including cancers and viral infections.

CAT: BRP-01625

CAS: 1253796-11-0

MF: C48H66N5O9PSi

MF: 916.12

Purity: >95%

Appearance: Off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: HWLSHLFHYPXASQ-HXZVCAGESA-N

Solubility: Soluble in Acetonitrile, DMF

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1O[Si](C)(C)C(C)(C)C)N2C=CC(=NC2=O)N(C)C(=O)C)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC

IUPAC Name: N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxyoxolan-2-yl]-2-oxopyrimidin-4-yl]-N-methylacetamide

InChI: InChI=1S/C48H66N5O9PSi/c1-33(2)53(34(3)4)63(59-31-17-29-49)61-43-41(60-45(44(43)62-64(12,13)47(6,7)8)52-30-28-42(50-46(52)55)51(9)35(5)54)32-58-48(36-18-15-14-16-19-36,37-20-24-39(56-10)25-21-37)38-22-26-40(57-11)27-23-38/h14-16,18-28,30,33-34,41,43-45H,17,31-32H2,1-13H3/t41-,43-,44-,45-,63?/m1/s1

Synonyms: 2'-OTBS C(Me,Ac) amidite; (2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(4-(N-methylacetamido)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite; N4-Acetyl-5'-O-DMTr-2'-O-TBDMS-N4-methyl cytidine 3'-CED phosphoramidite

2'-OTBS N3-Me-U amidite

Description: 2'-OTBS N3-Me-U amidite is a vital compound used in the field of biomedicine. With its therapeutic properties, this product is utilized for the development of targeted drugs catering to specific drug delivery systems, gene therapy, and immunotherapy.

CAT: BRP-01627

CAS: 179762-50-6

MF: C46H63N4O9PSi

MF: 875.07

Purity: >95%

Appearance: Off-white solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: BFLRLATZTWPEAW-SRYSXPHVSA-N

Solubility: Soluble in Acetonitrile, DMF

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1O[Si](C)(C)C(C)(C)C)N2C=CC(=O)N(C2=O)C)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC

IUPAC Name: 3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[tert-butyl(dimethyl)silyl]oxy-5-(3-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C46H63N4O9PSi/c1-32(2)50(33(3)4)60(56-30-16-28-47)58-41-39(57-43(42(41)59-61(11,12)45(5,6)7)49-29-27-40(51)48(8)44(49)52)31-55-46(34-17-14-13-15-18-34,35-19-23-37(53-9)24-20-35)36-21-25-38(54-10)26-22-36/h13-15,17-27,29,32-33,39,41-43H,16,30-31H2,1-12H3/t39-,41-,42-,43-,60?/m1/s1

Synonyms: 2'-O-tert-Butyldimethylsilyl-5'-O-DMT-3-methyluridine 3'-CE phosphoramidite; Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-3-methyl-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite]; (2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite; N3-Methyl Uridine CED phosphoramidite

Boc-PNA-G(Z)-OH

Description: Boc-PNA-G(Z)-OH is a synthetic peptide nucleic acid (PNA) monomer with a guanine base. It features a Boc (tert-butyloxycarbonyl) protecting group and a Z (benzyloxycarbonyl) group, commonly used in the synthesis of PNA oligomers for research in molecular biology and genetics, particularly in the study of DNA and RNA binding.

CAT: BRP-01691

CAS: 169287-77-8

MF: C24H29N7O8

MF: 543.54

Purity: ≥97% by HPLC

Appearance: White to Off-white Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C, in tightly closed container, protected from light and humidity

Density: 1.44±0.1 g/cm3

InChIKey: QPFRXGPXBKQVPU-UHFFFAOYSA-N

CanonicalSMILES: CC(C)(C)OC(=O)NCCN(CC(=O)O)C(=O)CN1C=NC2=C1N=C(NC2=O)NC(=O)OCC3=CC=CC=C3

IUPAC Name: 2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl-[2-[6-oxo-2-(phenylmethoxycarbonylamino)-1H-purin-9-yl]acetyl]amino]acetic acid

InChI: InChI=1S/C24H29N7O8/c1-24(2,3)39-22(36)25-9-10-30(12-17(33)34)16(32)11-31-14-26-18-19(31)27-21(28-20(18)35)29-23(37)38-13-15-7-5-4-6-8-15/h4-8,14H,9-13H2,1-3H3,(H,25,36)(H,33,34)(H2,27,28,29,35,37)

Synonyms: N-((N2-(Benzyloxycarbonyl)guanine-9-yl)acetyl)-N-(2-Boc-aminoethyl)glycine; Boc-G(Z)-Aeg-OH; Glycine, N-[[1,6-dihydro-6-oxo-2-[[(phenylmethoxy)carbonyl]amino]-9H-purin-9-yl]acetyl]-N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-; N-[2-[1,6-Dihydro-6-oxo-2-[[(phenylmethoxy)carbonyl]amino]-9H-purin-9-yl]acetyl]-N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]glycine

N6-Benzoyl-2'-tert-butyldimethylsilyl-7-deaza-5'-O-DMT-adenosine 3'-CE phosphoramidite

Description: N6-Benzoyl-2'-tert-butyldimethylsilyl-7-deaza-5'-O-DMT-adenosine 3'-CE phosphoramidite is essential for the synthesis of modified nucleic acids used in the research of various diseases. Its unique structure enables the introduction of N6-benzoyl, 2-tert-butyldimethylsilyl and 7-deaza functionalities into adenosine ideal for developing nucleoside analogs and exploring novel therapeutic strategies.

CAT: BRP-01716

CAS: 144994-95-6

MF: C54H67N6O8PSi

MF: 987.20

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: MUWOVNLLXDFHQS-QUWBCMLWSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1O[Si](C)(C)C(C)(C)C)N2C=CC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC

IUPAC Name: N-[7-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxyoxolan-2-yl]pyrrolo[2,3-d]pyrimidin-4-yl]benzamide

InChI: InChI=1S/C54H67N6O8PSi/c1-37(2)60(38(3)4)69(65-34-18-32-55)67-47-46(35-64-54(40-21-16-13-17-22-40,41-23-27-43(62-8)28-24-41)42-25-29-44(63-9)30-26-42)66-52(48(47)68-70(10,11)53(5,6)7)59-33-31-45-49(56-36-57-50(45)59)58-51(61)39-19-14-12-15-20-39/h12-17,19-31,33,36-38,46-48,52H,18,34-35H2,1-11H3,(H,56,57,58,61)/t46-,47-,48-,52-,69?/m1/s1

Synonyms: 7-Deaza Adenosine CED phosphoramidite; 7-Deaza 2'-TDDMS Adenosine(Bz) 3'-CE phosphoramidite; 7-Deaza-Adenosine CEP; N6-Benzoyl-2'-tert-butyldimethylsilyl-7-deaza-5'-O-DMT-D-adenosine 3'-CE phosphoramidite; N-[7-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-O-[(1,1-dimethylethyl)dimethylsilyl]-β-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]benzamide; Phosphoramidous acid, bis(1-methylethyl)-, mono(2-cyanoethyl) ester, ester with N-[7-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-O-[(1,1-dimethylethyl)dimethylsilyl]-β-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]benzamide

DMTr-FNA-C(Bz)phosphoramidite

Description: DMTr-FNA-C(Bz)phosphoramidite is an essential compound assuming the role of a phosphoramidite foundational component, expediting the fabrication of nucleic acid analogs. Through its distinctive configuration, it is harnessed in the fabrication of modified oligonucleotides, specifically tailored for investigative applications, notably in the precise targeting of disease-correlated DNA or RNA sequences encompassing afflictions like cancer and viral infections.

CAT: BRP-01746

CAS: 326802-62-4

MF: C45H52N5O8P

MF: 821.90

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: KYJJUEVQJPBHPG-UHFFFAOYSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OCC(COC(C1=CC=CC=C1)(C2=CC=C(C=C2)OC)C3=CC=C(C=C3)OC)OCN4C=CC(=NC4=O)NC(=O)C5=CC=CC=C5

IUPAC Name: N-[1-[[1-[bis(4-methoxyphenyl)-phenylmethoxy]-3-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxypropan-2-yl]oxymethyl]-2-oxopyrimidin-4-yl]benzamide

InChI: InChI=1S/C45H52N5O8P/c1-33(2)50(34(3)4)59(57-29-13-27-46)58-31-41(55-32-49-28-26-42(48-44(49)52)47-43(51)35-14-9-7-10-15-35)30-56-45(36-16-11-8-12-17-36,37-18-22-39(53-5)23-19-37)38-20-24-40(54-6)25-21-38/h7-12,14-26,28,33-34,41H,13,29-32H2,1-6H3,(H,47,48,51,52)

Synonyms: FNA C(Bz) amidite; N4-Benzoyl-1-[[2-O-(4,4'-dimethoxytrityloxy)-1-(hydroxymethyl)ethoxy]methyl]cytosine CED phosphoramidite; Phosphoramidous acid, bis(1-methylethyl)-, 2-[[4-(benzoylamino)-2-oxo-1(2H)-pyrimidinyl]methoxy]-3-[bis(4-methoxyphenyl)phenylmethoxy]propyl 2-cyanoethyl ester; 2-((4-Benzamido-2-oxopyrimidin-1(2H)-yl)methoxy)-3-(bis(4-methoxyphenyl)(phenyl)methoxy)propyl (2-cyanoethyl) diisopropylphosphoramidite

5'-O-DMT-2'-O-TBDMS-N4-Benzoyl-5-Methy-Cytidine 3'-CE phosphoramidite (BRP-01747)

Description: 5'-O-DMT-2'-O-TBDMS-N4-Benzoyl-5-Methy-Cytidine 3'-CE phosphoramidite, an indispensable tool in biomedicine, is utilized for oligonucleotide synthesis. Its application extends to treatments for cancer, viral infections, and genetic disorders, imparting significant progress in medical science. This product aptly aids the creation of innovative drugs and therapies that can possibly enhance patient outcomes.

CAT: BRP-01747

CAS: 160107-14-2

MF: C53H68N5O9PSi

MF: 978.21

Purity: ≥98%

Appearance: White to Off-white powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: CSRPNZIUSKVNCV-YIZRFDMBSA-N

CanonicalSMILES: CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)OP(N(C(C)C)C(C)C)OCCC#N)O[Si](C)(C)C(C)(C)C

InChI: InChI=1S/C53H68N5O9PSi/c1-36(2)58(37(3)4)68(64-33-19-32-54)66-46-45(35-63-53(40-22-17-14-18-23-40,41-24-28-43(61-9)29-25-41)42-26-30-44(62-10)31-27-42)65-50(47(46)67-69(11,12)52(6,7)8)57-34-38(5)48(56-51(57)60)55-49(59)39-20-15-13-16-21-39/h13-18,20-31,34,36-37,45-47,50H,19,33,35H2,1-12H3,(H,55,56,59,60)/t45-,46-,47-,50-,68?/m1/s1

Synonyms: 5-Me-rC(Bz) phosphoramidite; 5-Methyl Cytidine CED phosphoramidite; 5-Me-DMT-2'-O-TBDMS-C(Bz)-CE-Phosphoramidite; Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-5-methyl-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite]

2'-Fluoro-2'-deoxy Guanosine (N-iPrPAC) 3'-O-BMEG phosphoramidite

2'-Fluoro-2'-deoxy Uridine 3'-O-BMEG phosphoramidite

2'-Fluoro-2'-deoxy Adenosine (N-PAC) 3'-O-BMEG phosphoramidite

5-O-DMTr-1-O-Ac-2-F-2-deoxyribofuranose-3-CE-Phosphoramidite

5-DMTr-2-F-1,2-dideoxyribose-3-CE-Phosphoramidite

3'-F-3'-dA(Bz)-2'-phosphoramidite

5'-O-DMTr-2'-OMeU-methylphosphonamidite

5'-Cholesterol-CE Phosphoramidite (BRP-01617)

U-(S)-GNA phosphoramidite

N6-Benzoyl-5'-O-DMT-3'-O-methyladenosine 3'-CE-phosphoramidite

RSPACER CEP

2-Isobutyrylamino-9-(2'-O-tert-butyldimethylsilyl-5'-O-DMT-b-D-ribofuranosyl)purine 3'-CE phosphoramidite

2'-OMe N3-Me-U amidite

2'-O-tert-Butyldimethylsilyl-5-O-DMT-nebularine 3'-CE phosphoramidite

Cytidine, N-​acetyl-​5'-​O-​[bis(4-​methoxyphenyl)​phenylmethyl]​-​2'-​O-​[(1,​1-​dimethylethyl)​dimethylsilyl]​-​N-​methyl-​, 3'-​[2-​cyanoethyl N,​N-​bis(1-​methylethyl)​phosphoramidite]

2'-OTBS N3-Me-U amidite

Boc-PNA-G(Z)-OH

N6-Benzoyl-2'-tert-butyldimethylsilyl-7-deaza-5'-O-DMT-adenosine 3'-CE phosphoramidite

DMTr-FNA-C(Bz)phosphoramidite

5'-O-DMT-2'-O-TBDMS-N4-Benzoyl-5-Methy-Cytidine 3'-CE phosphoramidite (BRP-01747)

Cytidine, N-acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-[(1,1-dimethylethyl)dimethylsilyl]-N-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]